302 related articles for article (PubMed ID: 30465419)
1. Treatment of deep vein thrombosis with rivaroxaban and its potential to prevent the post-thrombotic syndrome.
Antignani PL; Allegra C; Fareed J
Int Angiol; 2019 Feb; 38(1):17-21. PubMed ID: 30465419
[TBL] [Abstract][Full Text] [Related]
2. Comparing short-term outcomes of femoral-popliteal and iliofemoral deep venous thrombosis: early lysis and development of reflux.
Singh H; Masuda EM
Ann Vasc Surg; 2005 Jan; 19(1):74-9. PubMed ID: 15714371
[TBL] [Abstract][Full Text] [Related]
3. Use of Micronized Purified Flavonoid Fraction Together with Rivaroxaban Improves Clinical and Ultrasound Outcomes in Femoropopliteal Venous Thrombosis: Results of a Pilot Clinical Trial.
Lobastov K; Schastlivtsev I; Barinov V
Adv Ther; 2019 Jan; 36(1):72-85. PubMed ID: 30539384
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound Aspects and Recanalization Rates in Patients with Lower-Limb Deep Venous Thrombosis Treated with Rivaroxaban.
de Athayde Soares R; Matielo MF; Brochado Neto FC; Almeida RD; Sacilotto R
Ann Vasc Surg; 2020 Aug; 67():293-299. PubMed ID: 31931131
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.
Lin M; Hsieh JCF; Hanif M; McDaniel A; Chew DK
J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):613-620. PubMed ID: 28818211
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the recanalization rate and postthrombotic syndrome in patients with deep venous thrombosis treated with rivaroxaban or warfarin.
de Athayde Soares R; Matielo MF; Brochado Neto FC; Nogueira MP; Almeida RD; Sacilotto R
Surgery; 2019 Dec; 166(6):1076-1083. PubMed ID: 31277885
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban versus warfarin in the prevention of post-thrombotic syndrome.
Jeraj L; Jezovnik MK; Poredos P
Thromb Res; 2017 Sep; 157():46-48. PubMed ID: 28692839
[TBL] [Abstract][Full Text] [Related]
8. Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis.
Sebastian T; Hakki LO; Spirk D; Baumann FA; Périard D; Banyai M; Spescha RS; Kucher N; Engelberger RP
Thromb Res; 2018 Dec; 172():86-93. PubMed ID: 30391776
[TBL] [Abstract][Full Text] [Related]
9. Low prevalence of Post-thrombotic syndrome in patients treated with rivaroxaban.
Ferreira T; Huber SC; de Moraes Martinelli B; Junior AL; Menezes FH; Orsi FA; Bittar LF; de Oliveira LFG; Sodre LR; Mello TT; Rielli G; Colella MP; de Paula EV; Yamaguti-Hayakawa GG; Montalvão S; Annichino-Bizzacchi JM
Vascul Pharmacol; 2020 Jan; 124():106608. PubMed ID: 31678199
[TBL] [Abstract][Full Text] [Related]
10. [Recanalization of lower-limb deep veins as an index of efficacy of treatment for acute venous thrombosis].
Kuznetsov MR; Sapelkin SV; Boldin BV; Leont'ev SG; Neskhodimov LA
Angiol Sosud Khir; 2016; 22(3):82-8. PubMed ID: 27626254
[TBL] [Abstract][Full Text] [Related]
11. Impact of concomitant popliteal vein thrombosis in patients with acute iliofemoral deep vein thrombosis treated with endovascular early thrombus removal.
Frey V; Sebastian T; Barco S; Spirk D; Hayoz D; Périard D; Kucher N; Betticher D; Engelberger RP
Vasa; 2022 Sep; 51(5):282-290. PubMed ID: 35774017
[No Abstract] [Full Text] [Related]
12. Resolution of acute lower extremity deep vein thrombosis with rivaroxaban compared to warfarin.
Houghton DE; Lekah A; Macedo TA; Hodge D; Saadiq RA; Little Y; Casanegra AI; McBane RD; Wysokinski WE
J Thromb Thrombolysis; 2020 Feb; 49(2):199-205. PubMed ID: 31422520
[TBL] [Abstract][Full Text] [Related]
13. Thrombosis in unusual sites of the lower extremity veins.
Labropoulos N; Bekelis K; Leon LR
J Vasc Surg; 2008 May; 47(5):1022-7. PubMed ID: 18358674
[TBL] [Abstract][Full Text] [Related]
14. Isolated Deep Venous Thrombosis: Implications for 2-Point Compression Ultrasonography of the Lower Extremity.
Adhikari S; Zeger W; Thom C; Fields JM
Ann Emerg Med; 2015 Sep; 66(3):262-6. PubMed ID: 25465473
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of rivaroxaban versus warfarin in the management of acute non-neoplastic portal vein thrombosis.
Hanafy AS; Abd-Elsalam S; Dawoud MM
Vascul Pharmacol; 2019 Feb; 113():86-91. PubMed ID: 29886103
[TBL] [Abstract][Full Text] [Related]
16. Home therapy with LMWH in deep vein thrombosis: randomized study comparing single and double daily administrations.
Bellosta R; Ferrari P; Luzzani L; Carugati C; Cossu L; Talarico M; Sarcina A
Angiology; 2007; 58(3):316-22. PubMed ID: 17626986
[TBL] [Abstract][Full Text] [Related]
17. Inflow thrombosis does not adversely affect thrombolysis outcomes of symptomatic iliofemoral deep vein thrombosis.
Jeyabalan G; Marone L; Rhee R; Hirsch S; Makaroun MS; Cho J; Chaer RA
J Vasc Surg; 2011 Aug; 54(2):448-53. PubMed ID: 21620617
[TBL] [Abstract][Full Text] [Related]
18. Outcomes after Rivaroxaban Treatment of Extensive Deep Vein Thrombosis.
Fujioka S; Kitamura T; Shikata F; Mishima T; Onishi Y; Araki H; Goto H; Sasahara A; Fukuzumi M; Torii S; Miyaji K
Ann Vasc Surg; 2022 Sep; 85():246-252. PubMed ID: 35288291
[TBL] [Abstract][Full Text] [Related]
19. Editor's Choice - Factors Associated with Long-Term Outcome in 191 Patients with Ilio-Femoral DVT Treated With Catheter-Directed Thrombolysis.
Foegh P; Jensen LP; Klitfod L; Broholm R; Bækgaard N
Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):419-424. PubMed ID: 28132743
[TBL] [Abstract][Full Text] [Related]
20. Analysis of 1,338 Patients with Acute Lower Limb Deep Venous Thrombosis (DVT) Supports the Inadequacy of the Term "Proximal DVT".
De Maeseneer MG; Bochanen N; van Rooijen G; Neglén P
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):415-20. PubMed ID: 26777542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
